These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7856296)

  • 41. Five year follow-up of morbidity and mortality among recipients of high-titre measles vaccines in Senegal.
    Aaby P; Samb B; Simondon F; Knudsen K; Seck AM; Bennett J; Markowitz L; Whittle H
    Vaccine; 1996 Feb; 14(3):226-9. PubMed ID: 8920704
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lessons from measles vaccination in developing countries.
    Hall AJ; Cutts FT
    BMJ; 1993 Nov; 307(6915):1294-5. PubMed ID: 8257878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measles virus antibody responses in children randomly assigned to receive standard-titer edmonston-zagreb measles vaccine at 4.5 and 9 months of age, 9 months of age, or 9 and 18 months of age.
    Martins C; Garly ML; Bale C; Rodrigues A; Njie-Jobe J; Benn CS; Whittle H; Aaby P
    J Infect Dis; 2014 Sep; 210(5):693-700. PubMed ID: 24688075
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immune response to Edmonston-Zagreb measles virus strain in monovalent and combined MMR vaccine.
    Beck M; Smerdel S; Dedić I; Delimar N; Rajninger-Miholic M; Juzbasić M; Manhalter T; Vlatković R; Borcić B; Mihajić Z
    Dev Biol Stand; 1986; 65():95-100. PubMed ID: 3556780
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Non-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trial.
    Aaby P; Martins CL; Garly ML; Balé C; Andersen A; Rodrigues A; Ravn H; Lisse IM; Benn CS; Whittle HC
    BMJ; 2010 Nov; 341():c6495. PubMed ID: 21118875
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Child mortality following standard, medium or high titre measles immunization in West Africa.
    Knudsen KM; Aaby P; Whittle H; Rowe M; Samb B; Simondon F; Sterne J; Fine P
    Int J Epidemiol; 1996 Jun; 25(3):665-73. PubMed ID: 8671571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Trial of Edmonston-Zagreb measles vaccine in infants aged under nine months.
    Pongrithsukda V; Gluck R; Suwatanapongched S; Kaewmalung P; Muyakul J
    Southeast Asian J Trop Med Public Health; 1991 Sep; 22(3):347-50. PubMed ID: 1818384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Measles vaccine immunogenicity in 6- versus 15-month-old infants born to mothers in the measles vaccine era.
    Johnson CE; Nalin DR; Chui LW; Whitwell J; Marusyk RG; Kumar ML
    Pediatrics; 1994 Jun; 93(6 Pt 1):939-44. PubMed ID: 8190581
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immunogenicity of the AIK-C measles vaccine in infants aged <9 months in Vietnam.
    Hong DT; Hien ND; Thao PTP; Anh DD; Mai HH; Huyen DTT; Huong NL; Phuong BH; Iijima M; Ito T; Nakayama T
    Vaccine; 2019 Jul; 37(32):4576-4580. PubMed ID: 31174936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long term impact of high titer Edmonston-Zagreb measles vaccine on T lymphocyte subsets.
    Lisse IM; Aaby P; Knudsen K; Whittle H; Andersen H
    Pediatr Infect Dis J; 1994 Feb; 13(2):109-12. PubMed ID: 8190534
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative study and evaluation of further attenuated, live measles vaccines alone and in combination with mumps and rubella vaccines.
    Wegmann A; Glück R; Just M; Mischler R; Paroz P; Germanier R
    Dev Biol Stand; 1986; 65():69-74. PubMed ID: 3556778
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children.
    Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
    J Infect Dis; 2004 Jan; 189(2):254-7. PubMed ID: 14722890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus.
    Christenson B; Böttiger M
    Vaccine; 1994 Feb; 12(2):129-33. PubMed ID: 8147093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The development and duration of immunity in children vaccinated against measles with the Edmonston-Zagreb vaccine].
    Borcić B; Smerdel S; Abu Eldan J; Kolić J; Ferdebar M; Kordić D; Mohacek N
    Lijec Vjesn; 1989; 111(4-5):131-4. PubMed ID: 2770398
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response.
    Sabin AB; Flores Arechiga A; Fernández de Castro J; Albrecht P; Sever JL; Shekarchi I
    JAMA; 1984 May; 251(18):2363-71. PubMed ID: 6368888
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Live-attenuated measles virus vaccine targets dendritic cells and macrophages in muscle of nonhuman primates.
    Rennick LJ; de Vries RD; Carsillo TJ; Lemon K; van Amerongen G; Ludlow M; Nguyen DT; Yüksel S; Verburgh RJ; Haddock P; McQuaid S; Duprex WP; de Swart RL
    J Virol; 2015 Feb; 89(4):2192-200. PubMed ID: 25473055
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Immuno-epidemiologic considerations on the prevention of measles in Mexico].
    Díaz-Ortega JL; Valdespino-Gómez JL; Zárate-Aquino ML; Camacho-Amor ML; González-Velázquez MS; Chávez-San Juan R
    Bol Med Hosp Infant Mex; 1990 Jul; 47(7):474-81. PubMed ID: 2206412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial.
    Martins CL; Garly ML; Balé C; Rodrigues A; Ravn H; Whittle HC; Lisse IM; Aaby P
    BMJ; 2008 Jul; 337():a661. PubMed ID: 18653640
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Response to measles revaccination among toddlers in Saudi Arabia by the use of two different trivalent measles-mumps-rubella vaccines.
    Khalil M; Poltera AA; al-Howasi M; Herzog C; Gerike E; Wegmüller B; Glück R
    Trans R Soc Trop Med Hyg; 1999; 93(2):214-9. PubMed ID: 10450452
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infants.
    Pabst HF; Spady DW; Carson MM; Krezolek MP; Barreto L; Wittes RC
    Vaccine; 1999 Apr; 17(15-16):1910-8. PubMed ID: 10217589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.